Business Segment |
Profit Margin |
|
|
2021 |
|
|
- |
2022 |
|
|
- |
2023 |
|
|
- |
2024 |
|
|
- |
2025 |
|
|
- |
United States |
|
|
- |
International |
|
|
- |
Medical Products Therapies |
|
|
- |
Healthcare Systems Technologies |
|
|
- |
Pharmaceuticals |
|
|
10.84 % |
United States Medical Products Therapies |
|
|
- |
United States Healthcare Systems Technologies |
|
|
- |
United States Pharmaceuticals |
|
|
- |
International Medical Products Therapies |
|
|
- |
International Healthcare Systems Technologies |
|
|
- |
International Pharmaceuticals |
|
|
- |
Infusion Therapies and Technologies Medical Products Therapies |
|
|
- |
Infusion Therapies and Technologies United States Medical Products Therapies |
|
|
- |
Infusion Therapies and Technologies International Medical Products Therapies |
|
|
- |
Advanced Surgery Medical Products Therapies |
|
|
- |
Advanced Surgery United States Medical Products Therapies |
|
|
- |
Advanced Surgery International Medical Products Therapies |
|
|
- |
Care and Connectivity Solutions Healthcare Systems Technologies |
|
|
- |
Care and Connectivity Solutions United States Healthcare Systems Technologies |
|
|
- |
Care and Connectivity Solutions International Healthcare Systems Technologies |
|
|
- |
Front Line Care Healthcare Systems Technologies |
|
|
- |
Front Line Care United States Healthcare Systems Technologies |
|
|
- |
Front Line Care International Healthcare Systems Technologies |
|
|
- |
Injectables and Anesthesia Pharmaceuticals |
|
|
- |
Injectables and Anesthesia United States Pharmaceuticals |
|
|
- |
Injectables and Anesthesia International Pharmaceuticals |
|
|
- |
Drug Compounding Pharmaceuticals |
|
|
- |
Drug Compounding International Pharmaceuticals |
|
|
- |
Other |
|
|
- |
Other United States |
|
|
- |
Other International |
|
|
- |
Emerging Markets |
|
|
- |
Rest of world |
|
|
- |
|
|